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F1F0-ATP synthase is a key enzyme of the mitochondrial energetic metabolism
responsible for the production of most cellular ATP in humans. Mayr et al. (2010)
recently described a patient with a homozygote (Y12C) mutation in the nuclear gene
ATP5E encoding the ε-subunit of ATP synthase. To better define how it affects ATP
synthase, we have modeled this mutation in the yeast Saccharomyces cerevisiae. A
yeast equivalent of this mutation (Y11C) had no significant effect on the growth of yeast
on non-fermentable carbon sources (glycerol/ethanol or lactate), conditions under which
the activity of the mitochondrial energy transducing system is absolutely essential. In
addition, similar to what was observed in patient, this mutation in yeast has a minimal
effect on the ATPase/synthase activities. On the contrary, this mutation which has been
shown to have a strong impact on the assembly of the ATP synthase complex in
humans, shows no significant impact on the assembly/stability of this complex in yeast,
suggesting that biogenesis of this complex differs significantly.
Keywords: ATP synthase, mitochondrial diseases, nuclear gene, yeast model, assembly
Introduction
Multi-protein complexes (I–V) embedded within the mitochondrial inner membrane are respon-
sible for the production of cellular energy generating ATP molecules through the process of
oxidative phosphorylation (OXPHOS). Defects in this process are responsible for severe diseases in
humans (Dimauro, 2011; Koopman et al., 2013). The OXPHOS system has a double genetic origin:
nuclear and mitochondrial. Pathogenic mutations that compromise cellular energy production can
therefore be found in both the nuclear and mitochondrial genomes.
Complexes I–IV transfer electrons to oxygen coupled to a vectorial proton translocation across
the mitochondrial inner membrane. The resulting transmembrane proton gradient is used by com-
plex V, the ATP synthase, to synthesize ATP from ADP and inorganic phosphate (Boyer, 1997;
Senior et al., 2002; Ackerman and Tzagoloﬀ, 2005;Walker, 2013). The ATP synthase consists of two
distinct domains, a globular matrix-localized catalytic unit called F1, and a membrane-embedded
proton-translocating domain known as F0. In mitochondria, F1 is an assembly of ﬁve diﬀerent
subunits with an α3β3γδε stoichiometry, that contains three catalytic sites located in the β-subunits
(Abrahams et al., 1994; Bianchet et al., 1998; Kabaleeswaran et al., 2006). The synthesis of ATP
by the β-subunits depends upon rotation of the F1 sub-complex (called the central stalk) formed
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by subunits γ, δ, and ε that connects F1 to the proton-
translocating domain (F0) of ATP synthase (Kabaleeswaran et al.,
2006). The main components involved in proton translocation
are a ring of c-subunits (8 in human and 10 in yeast; Stock et al.,
1999; Walker, 2013) and a single subunit a (Stock et al., 2000;
Fillingame et al., 2002). Direct contacts between the c-ring and
subunits γ and δ enable the c-ring and the central stalk to rotate
together as a ﬁxed ensemble during catalysis (Stock et al., 1999;
Tsunoda et al., 2001). The F1 is also physically connected to F0
via its external surface by a peripheral stalk, composed in yeast
of single copies of the subunits OSCP, 4, d, h, f, 8, and i (Velours
and Arselin, 2000; Ackerman and Tzagoloﬀ, 2005; Devenish et al.,
2008); this structure acts as a stator to counter the tendency of
the α3β3 moiety to follow the rotation of the central stalk dur-
ing catalysis. The mitochondrial ATP synthase exists as a dimer
(Arnold et al., 1998), a structure mediated by subunits e and g that
is important for cristae formation (Allen et al., 1989; Paumard
et al., 2002). The ATPase activity of the yeast mitochondrial ATP
synthase is also regulated by several peptides (If1, Stf1, and Stf2;
Hong and Pedersen, 2002).
The biogenesis of ATP synthase is a particularly complex pro-
cess, which involves a number of protein factors having speciﬁc
actions in the expression of the mitochondrial DNA-encoded
subunits and in the establishment of proper subunit interactions
(Ackerman and Tzagoloﬀ, 2005; Devenish et al., 2008; Rak et al.,
2009). The ATP synthase assembly pathway has been extensively
studied in Saccharomyces cerevisiae (Ackerman and Tzagoloﬀ,
2005; Kucharczyk et al., 2009; Rak et al., 2009, 2011a). Although
the yeast and human ATP synthases are highly similar, there must
be some diﬀerences in their assembly pathways, because factors
involved in the biogenesis of the yeast enzyme are not conserved
in humans and vice versa (Cizkova et al., 2008; Houstek et al.,
2009).
Diseases caused by ATP synthase defects have been associated
to mitochondrial DNA mutations in the genes encoding sub-
units a and A6L (Kucharczyk et al., 2009). Autosomal recessive
nuclear mutations have also been reported in genes (ATP12 and
TMEM70) encoding ATP synthase assembly factors (De Meirleir
et al., 2004; Cizkova et al., 2008) and structural subunits (ε and
α; Mayr et al., 2010; Jonckheere et al., 2013). All these mutations
share a common biochemical phenotype with a decreased content
of fully assembled ATP synthase.
The ε-subunit mutation was found in a 22 years old
patient presenting with neonatal onset, lactic acidosis, 3-
methylglutaconic aciduria, mild mental retardation, and periph-
eral neuropathy (Mayr et al., 2010). This was a homozygous
missense mutation replacing a highly conserved tyrosine in posi-
tion 12 of the protein with cysteine. This mutation caused a
substantial decrease in the rate of mitochondrial ATP synthesis
apparently because of a reduced content in fully assembled ATP
synthase. The authors concluded that ε-subunit has an essential
role in the biosynthesis and assembly of the F1 domain of ATP
synthase.
In the yeast S. cerevisiae, evidence was provided that the ε-
subunit is not required for the assembly of the other subunits
of ATP synthase (Tetaud et al., 2014). However, a lack in the ε-
subunit rapidly results in F0-mediated proton leaks through the
membrane, showing that the ε-subunit is in yeast essential for
the coupling of the F1 and F0 domains of ATP synthase (Tetaud
et al., 2014). In order to better understand how the Y12C muta-
tion in ε-subunit aﬀects ATP synthase, we have created a yeast
model of this mutation. The results show that this mutation has




Escherichia coli NEB-5alpha strain (BioLabs) was used for the
cloning and propagation of plasmids. The S. cerevisiae strains
used and their genotypes are listed in Table 1. The following rich
media were used for the growth of yeast: 1% (w/v) yeast extract,
1% (w/v) peptone, 40 mg/l adenine, 2% (w/v) glucose, 2% (w/v)
galactose, 2% (w/v) glycerol, or 2% (w/v) lactate. The glycerol
medium was buﬀered at pH 6.2 with 50 mM potassium phos-
phate, and 2% (w/v) ethanol was added after sterilization. We also
used complete synthetic medium (CSM) 0.17% (w/v) yeast nitro-
gen base without amino acids and ammonium sulfate, 0.5% (w/v)
ammonium sulfate, 2% (w/v) glucose, and 0.8% (w/v) of a mix-
ture of amino acids and bases from Formedium. The solid media
contained 2% (w/v) agar.
Construction of a Yeast Strain Expressing
the Yeast Subunit ε (WT and Mutant Y11C)
Yeast strain (YE1) expressing WT ε-subunit was described
previously (Tetaud et al., 2014). To obtain the yeast epsilon
Y11C mutant, the codon TAT (31/33) was mutated to TgT
to replace tyrosine 11 with cysteine. The coding sequence
of the ε-subunit gene (ATP15) was ampliﬁed by PCR with
Phusion DNA polymerase (Fermentas) using DNA from strain
W303-1B as a template and the primers EY11C-5Hind (5′-
aaaaagcttATGTCTGCCTGGAGGAAAGCTGGTATATCATgTG
GCTGCATATTTG-3′) that include the mutation (underlined)
for the sense strand and EY11C-3 (5′-aaagcggccgcCTATTTTG
TTATTGGAGTGGGTTCAGAAGCTGCAGTGCC-3′) for the
antisense strand. The PCR product was digested with HindIII–
NotI and ligated into the vector pES425 (marker leucine, Doron
TABLE 1 | Genotypes of yeast strains.
Name Nuclear genotype mtDNA Source
YE1 Matα ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX + pCM189-ATP15 ρ+Arg8m Tetaud et al. (2014)
Y11C Matα ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX + pES425-ATP15-Y11C ρ+Arg8m This study
hATP5E Matα ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX + pCM189-hATP5E ρ+Arg8m This study
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Rapaport) to produce plasmid pES425-Y11C. The cloned gene
was veriﬁed by DNA sequencing. The YE1 strain was trans-
formed with pES425-Y11C and selected on synthetic complete
medium lacking uracil and leucine. The resulting strain that
contains two diﬀerent plasmids (pCM189-ε WT and pES425-
Y11C) was subsequently cultured for about 10 generations in
a medium containing uracil allowing the lost of the pCM189-ε
WT plasmid. One clone called Y11C in a ρ+ state and containing
only pES425-Y11C plasmid was retained for further analysis.
Construction of a Yeast Strain Expressing
the Human Subunit ε (hATP5E) Under the
Control of a Doxycycline-Repressible
Promoter
The coding sequence of the human ε-subunit gene (ATP5E)
was ampliﬁed by PCR using cDNA obtained from human
HeLa cells as a template and primers hATP5E-5BamXho (5′-
tttggatccctcgagATGGTGGCCTACTGGAGACAGGCTGGACTC
AGC-3′) and hATP5E-3ClaNot (5′-aaagcggccgcatcgatTTATTC
CTTCTTTACTTTCACAATTTTTACGTTG-3′) for the anti-
sense strand. The PCR product was digested with BamHI–NotI
and ligated into the vector pCM189 (Gari et al., 1997) to produce
plasmid pCM189-hATP5E. The cloned gene was veriﬁed by DNA
sequencing. Y11C strain was transformed with pCM189-hATP5E
and selected on synthetic complete medium lacking uracil and
leucine. The resulting strain that contains two diﬀerent plasmids
(pES425-Y11C and pCM189-hATP5E) was subsequently cul-
tured for about 5–7 generations in a medium containing leucine
allowing the lost of the pES425-Y11C plasmid. One clone,
hATP5E wild-type (WT) human ε, isolated from a ρ+ clone,
and containing only pCM189-hATP5E plasmid was retained for
further analysis.
Miscellaneous Procedures
The oxygen consumption of cells was measured polarographi-
cally at 28◦C using a Clark oxygen electrode in a 1 ml ther-
mostatically controlled chamber. Respiratory rates were deter-
mined from the slope of a plot of O2 concentration versus time.
Cell oxygen consumption was measured in fresh cultured media
(CSM-galactose, OD600 = 2) and isolated mitochondria oxygen
consumption was measured in the respiration buﬀer (0.65 M
mannitol, 0.36 mM EGTA, 5 mM Tris-phosphate, 10 mM Tris-
maleate, pH 6.8) as previously described (Rigoulet and Guerin,
1979). Isolated mitochondria were prepared by the enzymatic
method (Guerin et al., 1979). The protein amounts were deter-
mined by the bicinchoninic acid assay (BCA; Smith et al., 1985)
in the presence of 5% SDS. For ATP synthesis rate measure-
ments, mitochondria (0.15 mg/ml) were placed in a 1-ml ther-
mostatically controlled chamber at 28◦C in respiration buﬀer.
The reaction was started by the addition of 4 mM NADH and
1 mM ADP and stopped with 3.5% perchloric acid and 12.5 mM
EDTA. The samples were then neutralized to pH 6.5 by the
addition of KOH and 0.3 M MOPS. ATP was quantiﬁed in a
luciferin/luciferase assay (PerkinElmer) with an LKB biolumi-
nometer. The speciﬁc ATPase activity was measured at pH 8.4
by using a previously described procedure (Somlo, 1968). The
activity of the F1F0-ATP synthase in ATP production was assessed
by oligomycin addition (20 μg/mg of protein). BN-PAGE exper-
iments were carried out as described previously (Schagger and
von Jagow, 1991). Brieﬂy, mitochondrial extracts solubilized
with digitonin to a protein ratio of 2 g/g were separated in a
3–12% acrylamide continuous gradient gel (Invitrogen). After
electrophoresis, the gel was either stained with Coomassie Blue
or incubated in a solution of 5 mM ATP, 5 mM MgCl2, 0.05%
lead nitrate, 50 mM glycine-NaOH, pH 8.4 to detect the ATPase
activity (Grandier-Vazeille and Guerin, 1996). Western blot anal-
yses were performed as previously described (Arselin et al., 1996).
Polyclonal antibodies raised against yeast ATP synthase were
used at a dilution of 1:50,000 for subunits Atp1; 1:10,000 for
subunits Atp3 and Atp4. Monoclonal antibodies against yeast
Porin and Cox2 (from Molecular Probes) were used at a dilu-
tion of 1:5,000. Nitrocellulose membranes were incubated with
peroxidase-labeled antibodies at a 1:5,000 dilution (Promega),
and the blot visualization was conducted with ECL reagent
(Pierce).
Results
Heterologous Expression of the Human
Epsilon Subunit in yeast
To model the ε-Y12C mutation in yeast, we ﬁrst determined
whether the WT human ε-subunit was able to complement yeast
cells lacking the endogenous ε-subunit gene ATP15 (atp15,
referred to as ε). Since ε cells have a high propensity
to lose their mitochondrial genome (Tetaud et al., 2014), we
proceeded as follows. WT yeast was ﬁrst transformed with
the yeast ATP15 gene cloned into a plasmid under the con-
trol of a doxycycline-repressible promoter. The native chro-
mosomal copy of ATP15 was then deleted, yielding strain
YE1 (Tetaud et al., 2014). The strain YE1 was next trans-
formed with a plasmid containing the human ε-subunit gene
(ATP5E), also under control of a doxycycline-repressible pro-
moter, and the plasmid containing the yeast ATP15 gene was
then eliminated (see “Materials andMethods”), yielding the strain
hATP5E.
The hATP5E and YE1 strains grew well on fermentable car-
bon source (glucose, Figure 1A). The strain YE1 grew well also
on non-fermentable carbon sources, like glycerol and lactate
(Figure 1A). As expected, the respiratory growth of strain YE1
was abolished by blocking the expression of yeast subunit ε with
doxycycline. In contrast, hATP5E cells expressing the human
ε-subunit grew very poorly on respiratory medium (Glycerol or
Lactate) with respect to YE1 cells (Figure 1A).
Although the yeast and human ε-subunit display a high level
of evolutionary conservation, the two proteins show a number
of amino-acids diﬀerences (Figure 1B). It is possible that the
human protein cannot interact properly with the yeast subunits
δ and γ. However, since cultures of the hATP5E strain contained
only less than 5% of petites lacking functional mtDNA, it can be
inferred that the human ε-subunit was probably assembled but
functions poorly. Indeed, as we have shown, a lack in subunit ε
in yeast results in massive protons that strongly destabilize the
mitochondrial genome (Tetaud et al., 2014).
Frontiers in Genetics | www.frontiersin.org 3 April 2015 | Volume 6 | Article 159
Sardin et al. Nuclear ATP synthase disorder
FIGURE 1 | Heterologous expression assays of human ε-subunit in
yeast. (A) Freshly grown cells of yeast expressing, human epsilon subunit
(hATP5E) and WT yeast epsilon subunit (YE1) were spotted onto glucose,
glycerol, and lactate media. Doxycyclin was added on plate at the concentration
of 10 μg/mL. The plates were incubated at 28◦C. (B) Sequence alignment
between human and yeast ε-subunit. Identical amino acids are highlighted in
black, similar amino acids in gray. Mutated Y12C in human or Y11C in yeast
sequences is indicated by an arrow. Identity 37%, similarity 59%.
Properties of Yeast Cells Expressing the
Yeast ε-Subunit Carrying an Equivalent
(Y11C) of the Human ε-Y12C Mutation
Due to the lack of complementation of ε yeast with the human
ε-subunit gene, we decided to investigate the consequences of
the ε-Y12C mutation using the yeast subunit ε with an equiva-
lent of this mutation. The strain YE1 was transformed with this
construct, yielding strain Y11C (see “Materials and Methods”).
Respiratory Growth and Oxygen Consumption
Y11C strain exhibited a nearly identically growth on both fer-
mentable (glucose) and non-fermentable (glycerol, lactate) car-
bon sources (Figure 2A). This does not imply that the Y11C
mutation has no deleterious eﬀects, since the rate of ATP syn-
thesis by the ATP synthase needs to be decreased by more than
70–80% in yeast to see an obvious respiratory growth defect
(Mukhopadhyay et al., 1994).
We next measured the rate of oxygen consumption on isolated
mitochondria. Using NADH as an electron donor, this activity
was reduced by approximately 20% in mitochondria from the
Y11C mutant with respect to those from the WT strain YE1,
at state 3 (i.e., in the presence of an excess of external ADP,
phosphorylating conditions; Figure 2B). With the addition of
NADH alone (state 4, basal respiration) respiration was in con-
trast slightly increased in Y11C mitochondria in comparison to
WTmitochondria, which is an indication that the passive perme-
ability to protons of the inner membrane was increased in the
mutant. Hence, the oxygen consumption rate was signiﬁcantly
less stimulated by ADP in the mutant than in the WT (2.4-fold
versus 3.7), which indicates that the rate of ADP phosphorylation
by the ATP synthase was slower in the mutant. The increased
passive permeability to protons was attributed to a slight insta-
bility of the expression system used (pES425, see “Materials and
Methods”), leading to an uncoupling of cells having lost the plas-
mid (Tetaud et al., 2014), but not necessarily an instability of
ε-subunit in the ATP synthase complex.
Mitochondrial ATP Synthesis/Hydrolysis and ATP
Synthase Assembly/Stability
The impact of the Y11C mutation on OXPHOS was further ana-
lyzed by measuring the rate of mitochondrial ATP synthesis with
NADH as a respiratory substrate, in the presence of large excess
of ADP (state 3). This activity was substantially reduced in the
Y11C mutant by 40% compared with the WT (Figure 2C). As
previously explained (see above), a small uncoupling will lead to
a decrease in the ATP synthesis activity which does not necessar-
ily reﬂect the impact of Y11C mutation. With only a 40% deﬁcit
in ATP production, it is normal that the Y11C mutant grew well
on respiratory substrates, for reasons explained above.
The rate of mitochondrial ATP hydrolysis (measured on non-
osmotically protected mitochondria) was not diminished, with
respect to the WT, by the Y11C mutation. Furthermore, this
activity was normally inhibited by oligomycin, indicating that the
physical and functional coupling of F1 to F0 wasmainly preserved
in the mutant (Figure 2D). Consistent with this, the mutated
F1F0-ATPase was correctly assembled and accumulated normally
in Y11C cells, as shown by BN-PAGE (Figure 2E) and SDS-PAGE
(Figure 2F) analyses.
Discussion
Biochemical investigation of ﬁbroblasts from patients carrying
the ε-Y12C has revealed a substantial decrease (60%) in the accu-
mulation of fully assembled ATP synthase with respect to control
cells. Similar decreases in the rate of mitochondrial ATP synthesis
and ATP hydrolysis, and in the steady-state concentrations of var-
ious subunits belonging to the F1 (α, β, ε) or the F0 (a, F6, d), were
observed in the ε-Y12C cells (Mayr et al., 2010). When expres-
sion of WT ATP5E gene encoding ε-subunit was reduced, the
biogenesis of ATP synthase was similarly inhibited (Havlickova
et al., 2010). However, neither the ε-Y12C mutation nor a block
in ε-subunit expression aﬀects the steady-state accumulation of
subunit c, which argues against a role of ε-subunit expression in
the regulation of human ATP synthase biogenesis. Such a role
has instead been ascribed to subunit c whose level of expression
was shown to determine the steady-state concentrations of all the
other subunits of the enzyme (Houstek et al., 1995; Andersson
et al., 1997). Indeed, in the absence of subunit c, all the other
ATP synthase subunits continue to be expressed at the same lev-
els, but because of the lack in subunit c they cannot assemble into
complete F1F0 complexes and are degraded (Houstek et al., 1995).
Studies in yeast have revealed that in the absence of ε-subunit,
the other subunits of ATP synthase can still assemble. However,
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FIGURE 2 | Biochemical analysis of yeast ε-Y11C mutant. (A) Freshly
grown cells of WT (YE1) and the mutant Y11C (Y11C) were spotted onto
glucose, glycerol, and lactate media. The plates were incubated at 28◦C.
(B) Oxygen consumption was measured on isolated mitochondria from WT
strain YE1 and mutant Y11C grown in glycerol/ethanol 2% medium at 28◦C.
Additions were 0.15 mg/ml proteins, 4 mM NADH, 150 μM ADP and 4 μM
CCCP (carbonyl cyanide m-chlorophenylhydrazone). The YE1 and Y11C
cultures contained about 3–5% ρ−/0 cells. (C,D) Measurements of ATP
synthase/ATPase activity on purified mitochondria from cells grown on
glycerol/ethanol 2%. White bar in ATP synthesis/hydrolysis represent
oligomycin insensitive ATPase activity and % of inhibition was indicated on
the bar. The values reported are averages of triplicate assays. (E) BN-PAGE
analyses of the ATP synthase. Mitochondria from WT (YE1) strain and yeast
Y11C mutant (Y11C) from cells grown on glycerol/ethanol 2%, were
solubilized with digitonin (2 g digitonin/g of protein). After centrifugation, the
mitochondrial complexes were separated by BN-PAGE and the gels
incubated with ATP and lead nitrate to reveal the ATPase activity (right)
followed by their staining with Coomassie Blue (left). V1 and V2 correspond
to monomeric and dimeric ATP synthase, respectively, and III2–IV2; III2–IV1
and III2 correspond to super-complexes III and IV. (F) Total extract proteins
were separated via SDS–PAGE and probed with antibodies against the
indicated proteins.
mitochondrial respiration is then uncoupled due to F0-mediated
proton leaks across the mitochondrial inner membrane (Tetaud
et al., 2014). It is believed that ε-subunit is required to maintain
δ-subunit in the ATP synthase under the torque imposed on this
subunit during rotation of the c-subunit ring. Upon the loss of
δ-subunit, the F0 can no longer associate to the F1 and the F0
then dissipates the mitochondrial membrane potential. Based on
the current structural models of yeast and bovine F1 (Figure 3A),
there is every reason to believe that ε-subunit has a similar role
in human ATP synthase. However, contrary to what happens
in yeast, a functional F0 does not assemble in the absence of
ε-subunit in humans, with notably the absence of subunit awhere
are located most of the residues involved in F0-mediated proton
movements. Furthermore, it was shown that while unassembled
F1 subunits aggregate in the matrix of yeast mitochondria, they
are rapidly degraded in HeLa cells (Rak et al., 2011b). It can be
inferred that diﬀerent mechanisms regulate the expression of F0
in humans and yeast.
The decreased content in ε-subunit in Y12C ﬁbroblasts is pos-
sibly due to a less eﬃcient incorporation/stability of the mutated
protein into the ATP synthase, followed by a rapid degradation of
the unassembled protein. However, the present study shows that
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FIGURE 3 | Model of mutated ε-subunit. (A) Alignment of γδε-subunits
of bovin (2XND.pdb) and yeast (2WPD.pdb) ATP synthase built with
PyMOL. γ, δ, and ε-subunits were colored in blue, orange and green,
respectively. (B) Magnification of panel A. Yeast tyrosine (Y11, red) of
ε-subunit and interaction with δ-subunit (δ-G73, δ-L52 in blue) are
indicated by yellow dashed line. (C) Magnification of panel A and
modelisation of the mutated tyrosine 11 in cysteine on the yeast
ε-subunit (C11, yellow).
the pathogenic ε-subunit mutation (Y12C, in humans; Y11C in
yeast) does not compromise the assembly of ε-subunit in yeast.
Based on this ﬁnding, we propose that the lack in ε-subunit
in the patient’s ﬁbroblasts has possibly another cause than a
defective assembly, like a less eﬃcient transport of this protein
into mitochondria or an increased susceptibility of the mutated
protein to proteolytic degradation. It is conceivable that the
ε-subunit interacts with some unknown protein until its incor-
poration into ATP synthase, and that this interaction is disrupted
by the ε-subunit mutation making the ε-subunit more prone to
degradation.
A 60% decrease in the rate of mitochondrial ATP synthe-
sis was observed in the Y12C ﬁbroblasts. Since, the content in
fully assembled ATP synthase was decreased in a similar propor-
tion, it was concluded that once assembled the mutated ε-subunit
works like the WT protein (Mayr et al., 2010). In a similar way
to humans, the ATPase/synthase activities of the yeast ATP syn-
thase seems little aﬀected by ε-subunit mutation, suggesting that
this mutation has little or no impact on the functioning of ATP
synthase. The mutated tyrosine residue establishes a few interac-
tions with δ-subunit that are predicted to be lost by replacing this
residue with cysteine (see Figures 3B,C). These interactions are
apparently not essential for the maintenance of δ-subunit within
ATP synthase. However, unlike to what has been observed in
humans, the assembly of the yeast ATP synthase was not aﬀected
at all by ε-subunit mutation, suggesting diﬀerences in assem-
bly/stability of the ATP synthase between yeast and humans.
In summary, if the ε-subunit mutation found in patients is
detrimental to mitochondrial energy-transduction in humans,
this mutation does not appear to have a strong impact on the yeast
mitochondrial ATP synthase. The ﬁndings reported in this study
point to the existence of important diﬀerences in the regulation
of ATP synthase biogenesis between yeast and humans, an issue
that would certainly deserve further studies for a better com-
prehension of how the mechanisms involved in mitochondrial
biogenesis adapted during the evolution of eukaryotes.
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